Faculty News

Doug Lowy receives Distinguished Scientist Award from the Association of American Cancer Institutes

Doug Lowy, M.D., Acting Director of NCI and Chief of the Laboratory of Cellular Oncology, has been selected to receive the Association of American Cancer Institutes (AACI) Distinguished Scientist Award. AACI is recognizing Dr. Lowy for his long-term research on the molecular biology of tumor viruses and growth regulation, his role in enabling the development of human papillomavirus (HPV) vaccines and his exploration of oncogenes and tumor suppressor genes and their signaling pathways.

CCR scientists receive the Presidential Early Career Award for Scientists and Engineers

John Brognard, Ph.D., Investigator in the Laboratory of Cell and Developmental Signaling, Romina Goldszmid, Ph.D., Investigator in the Cancer and Inflammation Program, and Anish Thomas, M.D., Investigator in the Developmental Therapeutics Branch, are recipients of the Presidential Early Career Award for Scientists and Engineers (PECASE). The PECASE is the highest honor bestowed by the United States Government to outstanding scientists and engineers who are beginning their independent research careers and who show exceptional promise for leadership in science and technology. Established in 1996, the PECASE acknowledges the contributions scientists and engineers have made to the advancement of science, technology, engineering and mathematics education and to community service as demonstrated by scientific leadership, public education and community outreach.

Jonathan Hernandez discusses surgical oncology with Behind the Knife podcast

Jonathan Hernandez, M.D., Investigator in the Surgical Oncology Program, was recently featured in a Behind the Knife podcast. During the episode, Dr. Hernandez discussed the surgical oncology match process and his research on ex vivo tissue preservation to study tumors. The full podcast is available online.

CCR fellows receive Conquer Cancer Foundation of ASCO Young Investigator Awards

Congratulations to Vid Leko M.D., Lekha Mikkilineni, M.D., and Chen Zhao, M.D., for receiving the Conquer Cancer Foundation of ASCO Young Investigator Award (YIA). The YIA provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this grant is to fund physicians during the transition from a fellowship program to a faculty appointment.

Nirali Shah and Lori Wiener participate in AtlanticLIVE summit

Nirali Shah, M.D., MHSc, Investigator in the Pediatric Oncology Branch (POB), and Lori Wiener, Ph.D., DCSW, LCSW-C, Staff Scientist in POB, recently participated in an AtlanticLIVE summit called Children and Cancer. During the event, they discussed their work developing immunotherapies and psychosocial standards of care for children with cancer. Watch their respective sessions here and here.

Udo Rudloff discusses germline mutations with Bloomberg podcast

Udo Rudloff, M.D., Ph.D., Investigator in the Pediatric Oncology Branch, was recently featured on Bloomberg’s Prognosis podcast.During the episode, “Should We Be Scared of Our DNA?," Dr. Rudloff discussed CDH1 germline mutations and risk of hereditary diffuse gastric cancer (HDGC) in an evolving environment, which he is currently studying as part of the Rare Tumor Initiative. The full podcast is available online.

Nataliya Buxbaum wins Magnetic Moments video competition

Nataliya P. Buxbaum, M.D., Assistant Clinical Investigator in the Experimental Transplantation and Immunology Branch, was named the overall winner of the International Society for Magnetic Resonance in Medicine’s Magnetic Moments Competition. The competition is designed for investigators to use video to describe their MRI-related research for a general audience. Dr. Buxbaum’s video describes her research using tracers to better and more safely image tumors.

Julius Strauss discusses promising immunotherapy drug for patients with HPV-related cancers

Julius Strauss, M.D., Assistant Research Physician in the Laboratory of Tumor Immunology and Biology, discussed a promising immunotherapy drug for patients with HPV-related cancers in a recent NCI Cancer Currents blog post. According to results from a phase 1 clinical trial, 33 percent of the 36 patients on the trial with HPV-positive tumors responded to the drug, and four of the responses lasted longer than 18 months. “This drug is a promising agent for patients with HPV-related cancers and may potentially benefit these patients more than traditional checkpoint therapies,” said Dr. Strauss.

Brid Ryan cohosts NCI Minority Health Month Facebook Live

The National Cancer Institute hosted a Facebook Live entitled, “A Dialogue on Cancer Disparities, Prevention, and Research.”The event featured Brid M. Ryan, Ph.D., M.P.H., Investigator in the Laboratory of Human Carcinogenesis, as well as Worta McCaskill-Stevens, M.D., M.S., from the Division of Cancer Prevention, and Christina Dieli-Conwright, Ph.D., M.P.H., from the University of Southern California. They discussed cancer disparities and the work being done to help reduce them.

Marston Linehan receives 2019 Urology Care Foundation Distinguished Mentor award

Marston Linehan, M.D., Chief of the Urologic Oncology Branch, has received the 2019 Urology Care Foundation Distinguished Mentor award. The award recognizes Dr. Linehan’s outstanding track record of fostering the next generation of urologic researchers by providing excellent training and guidance to early-career investigators.

Breadcrumb